Why has the Mounjaro pen been updated?
The update has been introduced to make it clearer when your pen has delivered all four doses and is ready to be discarded.
With the modified design, the plunger starts slightly lower in the cartridge before the pen is used, and an additional internal component allows it to move further forward by the time you’ve taken your fourth injection. This helps reduce uncertainty about whether any medication remains in the pen.
It’s worth emphasising that these are improvements to the device itself rather than changes to the treatment, and they don’t affect how the medication works in your body.
Why there may be less “extra” medication left in the pen
Some people using earlier versions of the KwikPen noticed that a small amount of liquid appeared to remain after completing all four injections. This is known as residual volume, and it’s included to support priming before each dose rather than to provide an additional injection.
With the updated design, the plunger now moves closer to the end of the cartridge after the fourth dose, which makes it clearer that the pen has reached the end of its intended use.
Even with previous versions of the device, each KwikPen has always been designed to deliver four weekly doses, and using any remaining liquid beyond those doses hasn’t been recommended. The updated design simply makes this easier to recognise at a glance.
Will the new pen change how you inject Mounjaro?
No, the injection process stays exactly the same.
The updated KwikPen still delivers the same medication, follows the same weekly dosing schedule, and uses the same injection technique you’re already familiar with.
When will the new Mounjaro pen be available in the UK?
The modified KwikPen is expected to begin appearing in the UK from April 2026. However, there isn’t a single nationwide switch-over date, because existing stock of the original pen will continue to be used during the transition period.
This means it’s completely normal to receive either version of the pen when your prescription is dispensed over the coming months. Both versions deliver the same treatment in the same way.
Why you might receive different versions during the transition period
Medication supply across the UK depends on a range of factors, including pharmacy ordering patterns and regional stock availability, which means some patients will receive the updated pen sooner than others.
During this transition period, it’s expected that both the original and modified KwikPens will be available at the same time across all dose strengths. This doesn’t affect your treatment, and it doesn’t mean anything has changed about your prescription.
Will this affect your prescription or treatment plan?
No, this update doesn’t change your prescribed dose or your injection schedule. Instead, it’s a device improvement designed to make dose completion clearer and help patients recognise more easily when their pen has reached the end of its intended use.
The numan take
From April 2026, you may begin to receive an updated version of the Mounjaro KwikPen - though during the transition period, both versions will remain in circulation. While the pen looks slightly different, nothing about your treatment has changed.
The update simply makes it easier to recognise when your final dose has been delivered, so it’s clearer at each stage of your injection routine.